Analysts Issue Forecasts for BCAX FY2026 Earnings
Bicara Therapeutics Inc. (NASDAQ:BCAX – Free Report) – Equities research analysts at Cantor Fitzgerald issued their FY2026 earnings per share (EPS) estimates for Bicara Therapeutics in a research note issued on Monday, June 9th. Cantor Fitzgerald analyst E. Schmidt anticipates that the company will post earnings of ($1.98) per share for the year. Cantor Fitzgerald […]
